The results revealed that SDS may exert preventive and therapeutic activities on NASH by regulating autophagy and apoptosis, enhancing immunity, and alleviating inflammation through targeting the protein of PPARα. Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.